NASDAQ OMX Derivatives Markets has carried out a re-calculation of options and futures in Novo Nordisk A/S (Novo Nordisk) due to a split. For details regarding the re-calculation please see exchange notice 75/13.

Adjusted series have received an “X” in the series designation, and have also received new ISIN-codes.

For further information, please see attached file.